Total
0
Shares
Source: Datametrex AI.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Datametrex subsidiary Medi-Call MD Inc. has launched its closed beta test for its Medi-Call health app for IOS users
  • The MediCall app is a subscription service that connects patients with doctors
  • Datametrex AI is a technology-focused company with exposure to artificial intelligence and machine learning
  • Shares in Datametrex AI Limited (DM) are up 2.70 per cent, trading at $0.19 per share

Last week, Datametrex AI (DM) launched the initial closed beta test for its Medi-Call health app for Android.

Now, the company’s subsidiary Medi-Call MD Inc. has also launched the beta test for IOS users.

Selected beta test users can now download the app, which provides accessible healthcare to people in rural or isolated areas, on their Apple devices.

The MediCall app is a subscription service that connects patients with doctors, providing technology-driven e-health care services including telehealth, live medical visits and prescriptions.

Patients can download the app and sign up by entering past medical history, current symptoms, and a designated pharmacy where they can pick up prescriptions.

“With millions of smartphone users in Canada, the MediCall App can reach patients outside of doctor offices and emergency rooms and is an essential tool for solving problems facing the increased demand on healthcare systems,” said Datametrex CEO Marshall Gunter.

“Datametrex is committed to making digital healthcare a mainstream activity,” he added.

Medi-Call initially launched in British Columbia and has now expanded across Canada, with services available for those with limited time, mobility, or transportation choices.

Datametrex AI is a technology-focused company with exposure to artificial intelligence and machine learning through its wholly-owned subsidiary, Nexalogy.

The company’s mission is to provide tools that support companies in fulfilling their operational goals, including health and safety, with predictive and preventive technologies.

Shares in Datametrex AI Limited (DM) are up 2.70 per cent, trading at $0.19 per share as of 9:30 am ET.

More From The Market Herald
Pluribus Technologies - CEO, Richard Adair.

" Pluribus Technologies completes equity financing

Pluribus Technologies has completed a C$25M equity financing.
The Market Herald Video

" LUXXFOLIO Holdings (CSE:LUXX) provides operational update

LUXXFOLIO Holdings’ (LUXX) November updates includes record mining revenues of approximately $1.8 million and monthly rewards of 23.5 Bitcoin.
Victory Square Technologies - CEO, Shafin Diamond Tejani

" Victory Square Technologies (CSE:VST) to issue the second tranche of dividend

Victory Square (VST) will issue the second tranche of its special dividend of common shares of portfolio company Fantasy 360 Technologies in December

" Upco International (CSE:UPCO) announces Q3 2021 interim financial results

Upco International (UPCO) focused on growing its wholesale telecom business in the third quarter, resulting in higher revenue.